DENTSPLY SIRONA Inc header image

DENTSPLY SIRONA Inc

XRAY

Equity

ISIN null / Valor 31773200

NASDAQ (2026-11-06)
USD 9.46-6.24%

DENTSPLY SIRONA Inc
UMushroom community rating:

star star star star star
4.00 1 votes No rating yet
NegativeNeutralPositive

About company

DENTSPLY SIRONA Inc is a global leader in the manufacturing of professional dental products and technologies, working in collaboration with partners to develop innovative solutions for dental professionals worldwide. With a mission to transform dentistry and improve oral health on a global scale, the company is dedicated to empowering dental practices, clinics, laboratories, and distributors to deliver top-quality dental care to patients. DENTSPLY SIRONA's research division plays a key role in driving the development of next-generation dental solutions, reflecting the company's commitment to advancing the field of dentistry.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-14.2%1Y
-66.9%3Y
-83.0%5Y

Performance

47.3%1Y
44.3%3Y
40.1%5Y

Volatility

Market cap

1886 M

Market cap (USD)

Daily traded volume (Shares)

10,284,544

Daily traded volume (Shares)

1 day high/low

18.86 / 18.36

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

4.00

1 votes
Performance:
starstarstarstarstar
2.00
Innovation:
starstarstarstarstar
4.00
Society:
starstarstarstarstar
3.00
Nature:
starstarstarstarstar
3.00
Matthew Tombaugh
Switzerland, 23 Mar 2026
star star star star star
A textbook deep value play. The stock is priced for failure at 8.9x earnings, but management is at the 10-yard line of a turnaround. Cutting the dividend to buy back shares at these depressed levels is a aggressive, shareholder-friendly move.

EQUITIES OF THE SAME SECTOR

Jubilant Pharmova Limited
Jubilant Pharmova Limited Jubilant Pharmova Limited Valor: 2477953
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.88%INR 938.60
Orion Oyj
Orion Oyj Orion Oyj Valor: 2553360
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%EUR 101.00
Beiersdorf AG
Beiersdorf AG Beiersdorf AG Valor: 324660
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.70%EUR 85.26
Bristol-Myers Squibb Co
Bristol-Myers Squibb Co Bristol-Myers Squibb Co Valor: 914188
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.57%USD 62.14
Medios AG
Medios AG Medios AG Valor: 19069483
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.53%EUR 11.34
Centene Corp
Centene Corp Centene Corp Valor: 1313733
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-5.97%USD 69.74
IQVIA Holdings Inc
IQVIA Holdings Inc IQVIA Holdings Inc Valor: 39103858
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.62%USD 271.83
Legend Biotech Corporation
Legend Biotech Corporation Legend Biotech Corporation Valor: 54834759
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.82%USD 23.40
2invest AG
2invest AG 2invest AG Valor: 110098281
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.25%EUR 6.32
The Platform Group AG
The Platform Group AG The Platform Group AG Valor: 57796644
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-13.06%EUR 0.55